its about the influenza viruses, its serogroups, its transmission and aloyt of things about its genome,its replication cycle , major outbreaks of bird flu and its treatment
3. Outline
• What is bird flu?
• Types of influenza
• Transmission
• Subtypes
• Genome
• Virus structure
• Replication cycle
• Symptoms and treatments
4. What is bird flu?
• Bird flu is also known as avian influenza
• It is caused by type A strains of influenza
• It infects birds ,animals and humans
• Mostly infects birds
• Similar to dog flu ,swine flu and human flu
• Reassortment forms a new virus
5. Types of influenza
There are basically three types of influenza
Influenza type A
Influenza type B
Influenza type C
A virus
Source of seasonal influenza epidemics and
pandemics
Affects both animals and birds
B and C viruses
Infects human only and not cause pandemics
6. Transmission
• This influenza type A virus is present in wild aquatic birds
• Then it infects birds , animals and humans
7. Sub types of avian influenza
There are 15 subtypes
Based on
Hemagglutinin
Neuraminidase
H5N1 infects mostly the birds
8.
9. Genome of bird flu virus
It belongs to family orthomyxoviridae
This family contain ssRNA viruses
Influenza virus has negative stranded ssRNA
There are 8 segments of RNA
11. Replication cycle
Most common steps :
Attachment (Adsorption)
Penetration
Uncoating
Targeting
Gene expression.
-synthesis of viral mRNA (transcription)
-synthesis of viral proteins (translation)
Genome replication
Virion assembly/maturation
Release of new infectious virus
12. Attachment
HA forms spikes on the viral lipid membrane.
These spikes of HA bind to sialic acid found on the surface of the
host membrane
Two major linkages are found between sialic acids and the
carbohydrates they are bound to in glycoproteins: α(2,3) and α(2,6)
Avians recognize the α(2,3) linkages
13.
14. Entry and uncoating
Cell mediated endocytosis occurs
Low Ph 5 to 6
Conformational changes in HA
Open the channels of matrix proteins
Viral RNP released into the cytoplasm
15. Transcription and replication of the viral
genome
Replication of the genome does not require a primer
The viral RNA dependent RNA polymerase (RdRp) initiates RNA
synthesis internally on viral RNA.
This is possible, as the extreme 5’ and 3’ ends of the genome exhibit
partial inverse complementarity
Are able to base pair with one another to form various corkscrew
configurations.
16. • Able to base pair with one another to form various
corkscrew configurations
17. Cap snatching
• Mature cellular messenger RNAs (mRNAs) have a 5’ methylated cap
and a poly(A) tail.
• The vRNPs have poly(A) tails but no 5’ caps
• It was determined that the 5’ methylated caps of the viral mRNAs
actually belonged to the cellular mRNAs
• Lead to the formulation of the “cap-snatching” mechanism
18. • The viral RdRp is made up of three viral proteins: PB1, PB2, and PA.
• PB2 has endonuclease activity.
• It binds to the 5’ methylated caps of cellular mRNAs
• Cleaves the cellular mRNAs’ 10 to 15 nucleotides 3’ to the cap
structure.
• This cellular capped RNA fragment is used by the viral RdRp to prime
viral transcription
19.
20. • cellular RNA Polymerase II (Pol II) binds to DNA and starts transcription
During transcription initiation, serine 5 on the C-terminal repeat domain
(CTD) of Pol II is phosphorylated, leading to the activation of cellular cap
synthesis complex
22. Export vRNPs out of nucleus
• vRNPs appear to be exported out of the nucleus via the CRM1
dependent pathway through the nuclear pores
Assembly and budding
• Uses the host cell’s plasma membrane to form the viral
particles
• That leave the cell and go on to infect neighbouring cells
• All the viral proteins normally found within the viral lipid
bilayer, i.e., HA, NA, and M2, must be present to form a viral
particle
26. Treatment
World Health Organization (WHO) currently recommend antiviral drugs
• oseltamivir (Tamiflu)
• zanamivir (Relenza)
• peramivir (Rapivab)
27. vaccine
The first vaccine in the United States for the prevention of H5N1
influenza
The vaccine was manufactured by Sanofi Pasteur
There are several hurdles to making a bird flu vaccine.
• It can take up to 6 months to produce and test each vaccine
• lack of overall production capacity
• One is the problem of scaling up production to meet demand